Skip to content

Clinical trials

Overweight trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Australia Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20091
20101
20112
20121
20142
20171
20182
20201
20214
20222
20237
20247
202516
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting21
Not yet recruiting12
Active, not recruiting9
Unknown status3
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company10
Novo Nordisk A/S8
Amgen5
AstraZeneca5
Zafgen, Inc.5
Biomed Industries, Inc.3
Kailera3
University of Melbourne3
University of Sydney3
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight79
Obesity75
Diabetes Mellitus, Type 210
Sleep Apnea, Obstructive7
Weight Loss6
Diabetes Mellitus3
Osteoarthritis3
Osteoarthritis, Knee3
Body Weight2
Insulin Resistance2

Trials

Showing 26 to 50 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.